Research programme: anti-anxiety compounds - SIDR
Latest Information Update: 05 Nov 2002
At a glance
- Originator Strathclyde Institute for Drug Research
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 05 Nov 2002 Discontinued for Anxiety disorders in United Kingdom (unspecified route)
- 19 Dec 2000 New profile
- 19 Dec 2000 Investigation in Anxiety disorders in United Kingdom (Unknown route)